URECHOLINE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Urecholine, and when can generic versions of Urecholine launch?
Urecholine is a drug marketed by Odyssey Pharms and is included in five NDAs.
The generic ingredient in URECHOLINE is bethanechol chloride. There are eight drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the bethanechol chloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Urecholine
A generic version of URECHOLINE was approved as bethanechol chloride by UPSHER SMITH LABS on June 1st, 2005.
Summary for URECHOLINE
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 5 |
Raw Ingredient (Bulk) Api Vendors: | 101 |
Clinical Trials: | 1 |
Patent Applications: | 1,469 |
Formulation / Manufacturing: | see details |
DailyMed Link: | URECHOLINE at DailyMed |
Recent Clinical Trials for URECHOLINE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Augusta University | Phase 1 |